Steve

[Steve @OTCSteve42]

$NWBO

[kristen shaughnessy @kshaughnessy2]

$NWBO

Why didn’t doctors at three prestigious cancer centers tell @HollensbeAmanda about a promising brain cancer treatment made by Northwest Biotherapeutics, an American company called DCVax?

Instead they told Amanda her 18 year old daughter, Braelyn, had one to three months to live?

Amanda found out about @NorthwestBio on X when longtime glioblastoma survivor @ThomasOwenMcCa1 saw her plea and reached out.

He made a call to the doctor who saved his life, Dr Linda Liau, at @UCLA.

June 2026
I saw her post on twitter & offered my help. I’m an 11 year survivor who got the phase 3 clinical trial of the DCVax administered by one of its creators Dr. Linda Liau of @UCLA .
I asked Dr. Liau personally if she could help with Braelyn.
https://t.co/sIFrT3iCJN

@gr197667 @MHRAgovuk @andrewcaravello @LisainNJUSA @RobertKennedyJr @michaelstrahan

[Steve @OTCSteve42]

$NWBO
High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical... https://t.co/F1axD33d6u

[Steve @OTCSteve42]

@EatYerShorts @TameVizsla Lol!!

[Steve @OTCSteve42]

@jaketapper Where'd you get that hat?? Love it and need one.

[Steve @OTCSteve42]

@og_tigress 👍

[Steve @OTCSteve42]

@BioNorthwest702 @MikeH3110 "We" ?????

[Steve @OTCSteve42]

@HollensbeAmanda Keep fighting Braelyn! You a hero and inspiration to all of us
.

[Steve @OTCSteve42]

$NWBO @60Minutes @CNN @MSNOWNews @ABC @NBCNews @CBSNews @BBCWorld @FoxNews

[Lou Smith 🍀 @smith348572]

$NWBO

@zubirahmed
@Siobhain_Mc
@Keir_Starmer
@wesstreeting
@METhompson72
@biggercapital

After more than 2.5 years in the MHRA process, the question is no longer whether a decision should be made on DCVax-L — the question is why a decision still has not been made.

At this point, I cannot help but wonder whether powerful interests are benefiting from continued delay. Every month that passes forces Northwest Biotherapeutics to raise additional capital, diluting shareholders and weakening the company financially. Whether intentional or not, the effect is the same.

It is also impossible to ignore the broader context. Northwest Biotherapeutics is currently pursuing litigation in the United States against several major market makers, alleging manipulative trading practices, including spoofing. These are some of the most powerful participants in the global financial system.

While I have no evidence that any regulatory body has been improperly influenced, it is fair to ask difficult questions when a company involved in such litigation experiences extraordinary delays. Large financial institutions often possess extensive networks of influence throughout the financial ecosystem. It is therefore reasonable for investors to question whether forces that benefit from delay may also be working, directly or indirectly, to prolong uncertainty surrounding this application.

The UK has repeatedly stated its ambition to become a global leader in cell and gene therapies. If that is truly the goal, this case sends exactly the wrong message to investors around the world.

Capital is the lifeblood of medical innovation. Investors fund the research, the clinical trials, the manufacturing infrastructure, and ultimately the therapies that patients desperately need. When a promising therapy remains in regulatory limbo for years, confidence in the system is damaged.

DCVax-L has demonstrated long-term survival benefits in glioblastoma, one of the deadliest forms of cancer. Approximately 13.5% of patients were alive at five years versus roughly 5% under standard care, with a long-tail survival benefit and minimal toxicity.

Meanwhile, patients continue to wait.
Investors continue to wait.
Doctors continue to wait.
The scientific community continues to wait.

Regardless of the final outcome, the MHRA owes patients, physicians, researchers, investors, and the public a clear and timely decision.

If the UK wishes to remain a destination for biotechnology investment and a leader in advanced therapies, transparency, predictability, and timely regulatory action are essential.

Two and a half years is enough.

https://t.co/Tg3T4Mvkuf

[Steve @OTCSteve42]

@HollensbeAmanda Trailblazing Braelyn!!

[Steve @OTCSteve42]

@CNN @MSNOWNews @WSJ @nypost @ABC @NBCNews @CBSNews @60Minutes

[Thomas Owen McCaffrey @ThomasOwenMcCa1]

Kenneth C. Griffin IS LAUGHING AT ALL THE PEOPLE DIAGNOSED WITH GLIOBLASTOMA MULTIFORME. (The most aggressive form of brain 🧠 CANCER.
People die everyday but this is different, he knows that there is a CURE FOR THIS BARBARIC DISEASE. But his hedge fund suppresses that CURE. Yes, @citsecurities the hedge fund he MANAGES is killing people every single DAY. & for what? GREED, how much money 💰 does he have to make before someone stops him. Let’s see how this plays out shall we. We already know the @SECGov is a JOKE.

@HollensbeAmanda @AZhalala @kshaughnessy2 @LisainNJUSA @NYMag @NorthwestBio @stephmase22 @ElvirPons @mcuban @TheLastWord @LastWeekTonight @hoffmann6383

[Steve @OTCSteve42]

@AlexZarac @LisainNJUSA @JoshTay02205534 @DoctorStock06 You are one sick individual

[Steve @OTCSteve42]

@smith348572 @CanadiensMTL @NHL I'm sorry Lou

[Steve @OTCSteve42]

@HollensbeAmanda Love this!! You've got this Braelyn!!

[Steve @OTCSteve42]

$NWBO

[Lou Smith 🍀 @smith348572]

$NWBO

Other than the possibility that hedge funds and market makers somehow managed to corrupt thE @MHRAgovuk , I honestly do not see any reason why DCVax-L would not be approved. The data, safety profile, and unmet medical need all strongly support approval.

@wesstreeting
@Siobhain_Mc
@Keir_Starmer
@zubirahmed

[Steve @OTCSteve42]

$NWBO it's all about the vaccine!!

[Steve @OTCSteve42]

$NWBO

[Tickeron @Tickeron]

The Northwest Biotherapeutics Empire Forecast 2030: Why Northwest Biotherapeutics Is the Most Underestimated Cancer Immunotherapy Company in the World
$NWBO $REGN $INCY $EXEL $MRNA $ARWR $BCRX $ADPT $SRPT $NVAX $NKTR
https://t.co/YpmbX7gzln

[Steve @OTCSteve42]

$NWBO @MHRAgovuk Today would be a good day......

[Steve @OTCSteve42]

$NWBO Approval Now!!

[Andrew Caravello, DO @andrewcaravello]

You asked to hear from patients and families. They have been waiting 27+ months on the $NWBO #DCVax MAA. #Glioblastoma is a rare cancer. Median survival is 14 months. A new way forward starts with the application already on your desk.

[Steve @OTCSteve42]

@smith348572 @MHRAgovuk ⬆️⬆️⬆️⬆️⬆️⬆️⬆️
All of what he said !!!

[Steve @OTCSteve42]

@Michael48826289 @JdBell20 @CscottLawyer Easy ... JD is one of the good guys and a must follow